Breaking News Instant updates and real-time market news.

TARO

Taro Pharmaceutical

$86.27 /

+0.43 (+0.50%)

15:01
01/10/20
01/10
15:01
01/10/20
15:01

Taro Pharmaceutical issues voluntary recall of Lamotrigine

Taro Pharmaceuticals is voluntarily recalling one lot of Lamotrigine 100 mg Tablets, Lot # 331771 in 100 count bottles, NDC 51672-4131-1 to the consumer level. This single lot was found to have been cross-contaminated with a small amount of another drug substance, Enalapril Maleate, used to manufacture another product at the same facility. Taro has not received any product complaints or adverse events related to contamination of this product with Enalapril, or any complaints or adverse events that are associated specifically with this recall. Taro will continue to actively monitor for any and all adverse event reports that may be received, in compliance with FDA regulatory requirements.

TARO Taro Pharmaceutical
$86.27 /

+0.43 (+0.50%)

08/12/19 H.C. Wainwright
Taro Pharmaceutical price target lowered to $105 from $115 at H.C. Wainwright

TODAY'S FREE FLY STORIES

General news
Powell: the subtle shift in language on the 2% inflation goal » 14:50
01/29/20
01/29
14:50
01/29/20
14:50

Powell: the subtle shift…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Tesla options imply 15.6% move in share price post-earnings » 14:49
01/29/20
01/29
14:49
01/29/20
14:49
TSLA

Tesla

$581.84 /

+15.03 (+2.65%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Fed Chair Powell opened his presser » 14:45
01/29/20
01/29
14:45
01/29/20
14:45

Fed Chair Powell opened…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Fed's Powell 'not comfortable' with inflation persistently under 2% » 14:42
01/29/20
01/29
14:42
01/29/20
14:42
SPY

SPDR S&P 500 ETF Trust

$328.05 /

+1.14 (+0.35%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

Fed Chair Jerome Powell…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
U.S. Steel 'applauds' collaborative USMCA adoption » 14:41
01/29/20
01/29
14:41
01/29/20
14:41
X

U.S. Steel

$9.36 /

+0.175 (+1.91%)

United States Steel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Grand Canyon issues response to 'inaccurate and misleading' Citron report » 14:39
01/29/20
01/29
14:39
01/29/20
14:39
LOPE

Grand Canyon

$82.09 /

-2.105 (-2.50%)

On its corporate website,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Teck CEO says 'anyone's guess' whether Canada will clear Frontier, Reuters says » 14:39
01/29/20
01/29
14:39
01/29/20
14:39
TECK

Teck Resources

$13.40 /

-0.09 (-0.67%)

Teck Resources CEO Don…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General News
Interior Department puts temporary limits on drones amid China fears » 14:38
01/29/20
01/29
14:38
01/29/20
14:38
AMBA

Ambarella

$58.69 /

-0.3 (-0.51%)

, BA

Boeing

$325.72 /

+9.1 (+2.87%)

, GPRO

GoPro

$4.22 /

-0.24 (-5.38%)

, LMT

Lockheed Martin

$436.59 /

-0.41 (-0.09%)

, AVAV

AeroVironment

$67.05 /

-0.34 (-0.50%)

U.S. Secretary of the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
MNG Enterprises reports 5.9% stake in Lee Enterprises » 14:38
01/29/20
01/29
14:38
01/29/20
14:38
LEE

Lee Enterprises

$2.30 /

+1.05 (+84.00%)

MNG Enterprises acquired…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
General news
January FOMC statement was nearly identical to December's, with only two edits » 14:35
01/29/20
01/29
14:35
01/29/20
14:35

January FOMC statement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
PNM Resources trading resumes  14:31
01/29/20
01/29
14:31
01/29/20
14:31
PNM

PNM Resources

$54.38 /

+0.05 (+0.09%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Fly Intel: What to watch in Eli Lilly earnings report » 14:28
01/29/20
01/29
14:28
01/29/20
14:28
LLY

Eli Lilly

$140.93 /

+1.73 (+1.24%)

, DERM

Dermira

$18.75 /

-0.05 (-0.27%)

, INCY

Incyte

$75.05 /

-1.38 (-1.81%)

Eli Lilly (LLY) is…

Eli Lilly (LLY) is scheduled to report the results its fourth fiscal quarter before the market open on Thursday, January 30, with a conference call scheduled for 9:00 am EDT. What to watch for 1. GUIDANCE: Along with its third quarter report in late October, the drug giant raised its fiscal year 2019 earnings per share guidance to $5.75-$5.85 from $5.67-$5.77, while reaffirming its FY19 revenue view of $22B-$22.5B. For Q3, Lilly's revenue in the U.S. increased 3%, driven by 8% volume growth. 2. NEWER DRUGS LEAD GROWTH: Key growth products launched since 2014, including Trulicity, Taltz, Jardiance, Verzenio, Olumiant, Emgality, Basaglar, and Cyramza, contributed 12 percentage points of revenue growth and represented approximately 44% of total revenue in Q3. "Lilly continued to deliver strong results in the third quarter, due in large part to the growth of our newer medicines and our ability to effectively manage costs," said Eli Lilly CEO David Ricks. "Lilly's revenue growth is being driven by volume, not price, as more and more patients are benefiting from our recently launched medicines." 3. DERMIRA ACQUISITION. On January 10, Eli Lilly agreed to acquire US-based biopharmaceutical company Dermira (DERM) in a deal valued at around $1.1B. Lilly will pay $18.75 per share in cash to buy the Menlo Park-based Dermira, which develops novel therapies to treat patients with chronic skin conditions. The acquisition of Dermira will help Lilly to expand its immunology pipeline with the addition of lebrikizumab. Lebrikizumab was granted Fast Track designation from the FDA in December 2019. RECENT PIPELINE DEVELOPMENTS: Also this month, Eli Lilly jointly announced with Innovent Biologics, the results of a Phase 3 study in China; the ORIENT-11 trial of Tyvyt in combination with Alimta and platinum in first-line advanced or recurrent nonsquamous non-small cell lung cancer. The study met the predefined primary endpoint of progression-free survival, or PFS, in an interim analysis. Additionally, Eli Lilly and Incyte (INCY) announced that baricitinib met the primary endpoint in BREEZE-AD4, an investigational Phase 3 study for the treatment of adult patients with moderate to severe atopic dermatitis, or AD.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
L Brands in talks for PE firm Sycamore to take Victoria's Secret stake, WSJ says  14:26
01/29/20
01/29
14:26
01/29/20
14:26
LB

L Brands

$23.07 /

+2.51 (+12.21%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
PNM Resources says New Mexico Supreme Court granted joint petition » 14:25
01/29/20
01/29
14:25
01/29/20
14:25
PNM

PNM Resources

$54.38 /

+0.05 (+0.09%)

The New Mexico Supreme…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Federal Reserve Chairman Powell to hold a press conference » 14:25
01/29/20
01/29
14:25
01/29/20
14:25

Federal Reserve Chairman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Technical Analysis
Technical Earnings Preview: Tesla » 14:24
01/29/20
01/29
14:24
01/29/20
14:24
TSLA

Tesla

$579.57 /

+12.76 (+2.25%)

There is an active…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Lyft tells Bloomberg it is cutting 90 employees, or 1.6% of staff » 14:22
01/29/20
01/29
14:22
01/29/20
14:22
LYFT

Lyft

$46.96 /

-1.25 (-2.59%)

Lyft said in a statement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Treasury Action: Treasury rates were little changed on the FOMC's stance » 14:20
01/29/20
01/29
14:20
01/29/20
14:20

Treasury Action: Treasury…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Technical Analysis
NASDAQ market internals summary » 14:17
01/29/20
01/29
14:17
01/29/20
14:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Technical Analysis
NYSE market internals summary » 14:16
01/29/20
01/29
14:16
01/29/20
14:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Philip Morris put volume heavy and directionally bearish » 14:15
01/29/20
01/29
14:15
01/29/20
14:15
PM

Philip Morris

$84.48 /

-0.2 (-0.24%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FOMC left policy unchanged » 14:15
01/29/20
01/29
14:15
01/29/20
14:15

FOMC left policy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
FX Action: The dollar » 14:15
01/29/20
01/29
14:15
01/29/20
14:15

FX Action: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Fed Chair Press Conference to be released at 14:30  14:15
01/29/20
01/29
14:15
01/29/20
14:15
 
General news
Fed Chair Press Conference to be released at 14:30  14:15
01/29/20
01/29
14:15
01/29/20
14:15
 

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.